About: PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.35 (+3.82%)
PMCB NASDAQ PharmaCyte Biotech Inc
PharmaCyte Biotech Inc share price
Atividade de preço de PMCB
Último preço
$ 0,350
Variação (24h)
0,01 USD (3,82%)
Volume
12.23K
Volume (média 4 sem.)
-
Abertura
$ 0,35
Variação do dia
$ 0,33 - $ 0,38
Fechamento anterior
$ 0,33
Último negócio
29 Oct, 4:20 pm GMT+0
Atrasado
29 Oct, 4:20 pm GMT+0
PMCB price performance
Atrasado
29 Oct, 4:20 pm GMT+0
quote.marketSignals